insights_auto
Why is INO down 2,05%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,43 US$
arrow_downward
-2,05%(-0,030) 1D
13 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,44 US$
High
1,48 US$
Low
1,39 US$
Mkt. cap
267,85 მლნ.
Avg. vol.
19,26 მლნ.
Volume
0,00
52-wk high
2,72 US$
52-wk low
0,56 US$
EPS
-0,80 US$
Beta
1,71
Shares outstanding
187,31 მლნ.
No. of employees
112
Open
1,44 US$
High
1,48 US$
Low
1,39 US$
Mkt. cap
267,85 მლნ.
Avg. vol.
19,26 მლნ.
Volume
0,00
52-wk high
2,72 US$
52-wk low
0,56 US$
EPS
-0,80 US$
Beta
1,71
Shares outstanding
187,31 მლნ.
No. of employees
112
News stories
From web sources and news partners
BigGo Finance
·
16 საათის წინ
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
11 საათის წინ
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
TradingKey
·
1 დღის წინ
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
StoneX
·
2 დღის წინ
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc